There are six isoforms of PLD, PLD1-6, of which PLD1 and PLD2 isoforms exhibit the ability to hydrolyze phospholipids and these two isoforms have been widely recognized in several human pathophysiologies including cancer, hypertension, neurodisorders, diabetes, and acute lung injury [228,229,230,231]. This evidence concerns the gene PLD1 and cancer.